Real-time enrollment status for this nk-cell lymphoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 2:35 PM UTC
| NCT Number | NCT03719105 |
| Recruiting Status | Recruiting |
| Condition | NK-Cell Lymphoma |
| Phase | EARLY_PHASE1 |
| Target Enrollment | 40 participants |
| Active Locations | 6 sites in the US |
| Sponsor | New York Medical College |
| Last Updated on CT.gov | August 18, 2026 (Aug 18, 2026) |
As of October 12, 2026: Clinical trial NCT03719105 is currently recruiting participants. This early_phase1 study for nk-cell lymphoma is actively seeking new participants at 6 locations across the United States. The study is sponsored by New York Medical College. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03719105 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03719105 was last updated Aug 18, 2026 (August 18, 2026). HelloStudys verifies this status automatically.